Abstract:
Background; -. The emergence of drug-resistant tuberculosis is currently a challenge for the End-
TB strategy. Globally in 2018 alone, there were about three hundred ninety thousand new cases
of Multidrug-resistant tuberculosis (MDR-TB The MDR-TB treatment success rate of St. Peter
Specialized Hospital is in a decreasing pattern. Furthermore , Delay to initiate the chemotherapy
after diagnosis is noticed. However, the reason is not assessed from a holistic perspective yet.
Objective; - To assess the quality of Multi-Drug Resistant Tuberculosis treatment service in St.
Peter specialized hospital, Ethiopia, 2020.
Methods and Materials; - The formative evaluation was conducted from April 1to April 21 2020
by applying the Donabedian framework for quality assessment in St. Peter specialized hospital. A
single case study design was selected. It was assessed based on availability, compliance, Interim
clinical outcome, and satisfaction dimensions. Moreover, twenty provider-patient interactions
observation, thirteen Key informant interviews, and all patient charts for the last two years
reviewed, and all patients currently on treatment were interviewed. The inventory and chart
review checklists were taken from the national guideline. The observation and interview tools
were adapted from different literatures. Thematic analysis technique was applied for the
qualitative data. And for the quantitate data, Descriptive summary and principal component
analysis were done by SPSS 25.
Result: - The evaluation finding indicate resource availability scores of 77.7%. The absence of
culture laboratory, shortage of training for the staff were the identified gaps. And interrupted
supply of plumpy-nut and chemistry test reagents were the uncovered problem. The compliance
score was 68%. Baseline and follow up physical examinations were done only for less than
half(48.5%) of the patients. Only 31.4% of patients had a second-line drug sensitivity test. There
was no supportive supervision in the last six months. The social support covers 65% of the eligible
clients. The interim clinical outcome scores 88%. Whereas, the overall satisfaction score with
multidrug-resistant TB is 75.6%. The overall quality based on the judgment parameter was good.
Conclusion and Recommendation: - Interruptions of Ready To use therapeutic food supply,
laboratory reagent should be managed by the hospital. The culture laboratory should be finished.
Provision of social support, on-job training and supportive supervision with written timely
feedback should be improved by the Ministry of Health.
